Navigation Links
Feinstein Institute to Receive $330,000 Grant to Support Research of Childhood Cancer
Date:9/19/2013

Manhasset, NY (PRWEB) September 19, 2013

The Feinstein Institute for Medical Research announced today it will receive $330,000 in grants aimed at gaining a better understanding of a pediatric cancer syndrome called Diamond Blackfan anemia. The grants were awarded by the St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated to raising money for childhood cancer research. It will support the work of a Feinstein Institute physician-researcher and consortium.

Sharon Singh, MD, will receive $230,000 to support her research project focused on Diamond Blackfan anemia. Diamond Blackfan anemia is an inherited condition that leads to anemia, possible birth defects and cancer. Dr. Singh’s team is working to understand the conditions that promote the formation and survival of cancer cells in this syndrome, to improve early diagnosis and treatment of childhood cancer.

“I am very thankful to receive this grant as it will support me in working to identify what conditions may lead to the development of cancer in children,” said Dr. Singh. “If my colleagues and I can identify why certain children develop cancer while others do not, we may be able to prevent future children from suffering from cancer.”

The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium at the Feinstein Institute, led by Johnson Liu, MD, will receive $100,000 to support ongoing work. The consortium is focused on a group of childhood disorders including Diamond-Blackfan anemia. Specifically, the researchers who comprise the consortium are exploring different ways they can manage Diamond-Blackfan anemia once a patient is diagnosed with it so that it doesn’t lead to anemia and cancer.

“The Pediatric Myelodysplastic Syndromes and Ribosome Dysfunction Consortium is a very unique group – I don’t know of another group in the world that has the concerted effort and capability to study Diamond Blackfan anemia or pre-leukemia in children,” said Dr. Liu. “The support by the St. Baldrick’s Foundation will enable us to continue and expand our research and hopefully identify new ways to manage or treat this deadly disease.”

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11131404.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
2. Summer Benefit Concert Raised More Than $1.5 Million for Feinstein Institute
3. Long Island Bike Challenge Rides to Raise Money for North Shore-LIJ's Feinstein Institute of Medical Research
4. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
5. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
6. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
7. Feinstein Institute Researcher provides insight into osteoarthritis
8. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
9. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
10. Feinstein Institute researchers discover plant derivative
11. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the American ...
(Date:8/18/2017)... ... 18, 2017 , ... Radabaugh & Associates, a family managed ... North-Central West Virginia, is embarking on a cooperative charity effort with the Chestnut ... The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates Insurance Agency, ... commercial clients in the greater Houston region, is helping locally recognized nonprofit Addi’s ... against cancer. , Founded by Tony and Amber Bender after losing their young ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... says will lift the veil on false teachings pertaining to the mother of the Savior ... teach, you see a far different picture of the role of this historical woman. ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: A ... a couple that grew stronger together through the faith they shared to overcome struggles ... is the creation of published author, Barbara J. Corcoran, a retired teacher and happily ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced financial ... unless otherwise noted, are to the quarter ended June 30, ... 2017 Highlights include: Revenue of $1,126 ... Total prescriptions dispensed of 220,000, compared to 241,000 ... Gross profit per prescription dispensed of $371, ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... , Aug. 2, 2017   Marshall County Hospital in Benton, Kentucky ... reduce the risk of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short ... to kill deadly pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
Breaking Medicine Technology: